Bioscience

CSU, Synaptive Medical collaborate to improve brain tumor detection

CSU, Synaptive Medical collaborate to improve brain tumor detection

FORT COLLINS -- Colorado State Universitys Flint Animal Cancer Center and Toronto-based Synaptive Medical Inc. are collaborating to develop an intraoperative imaging and sensing technology to... Read More

Thursday May 25, 2017 0 comments Tags: Fort Collins, CSU Flint Animal Cancer Center, Dr. Rebecca Packer, Cameron Piron, Synaptive Medical

CB Scientific’s CannaRAPID offers hope for combatting opioid drug addiction

CB Scientific’s CannaRAPID offers hope for combatting opioid drug addiction

DENVER -- CB Scientific, Inc . (OTC PINK: CBSC), a designer, developer and manufacturer of cannabis analytical tools and devices, cannabis medical delivery systems and personal analytical kits... Read More

Wednesday May 24, 2017 0 comments Tags: CB Scientific, opioid addiction, Denver, CannaRAPID, Bobban Subhadra

Muse bio appoints John Stuelpnagel chairman of board of directors

Muse bio appoints John Stuelpnagel chairman of board of directors

BOULDER -- Muse bio , a privately-held company leading the development of next-generation genome engineering capabilities, announced Dr. John Stuelpnagel , co-founder, first CEO and former COO... Read More

Tuesday May 16, 2017 0 comments Tags: Boulder, Muse bio, John Stuelpnagel, Dr. Kevin Ness, ForgeCraft

Aytu BioScience acquires Nuelle female sexual health company

Aytu BioScience acquires Nuelle female sexual health company

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced the acquisition of... Read More

Wednesday May 10, 2017 0 comments Tags: Englewood, Aytu BioScience, Nuelle, Fiera, Josh Disbrow

Array BioPharma announces strategic collaboration with Merck

Array BioPharma announces strategic collaboration with Merck

BOULDER -- Array BioPharma Inc .(Nasdaq: ARRY) announced it has entered into a clinical trial collaboration agreement with Merck (known as MSD outsidethe United StatesandCanada) to investigate... Read More

Tuesday May 9, 2017 0 comments Tags: Boulder, Array BioPharma, Merck, Ron Squarer, binimetinib, KEYTRUDA

Ceyta Therapeutics announces $220K seed round led by InSynchrony

Ceyta Therapeutics announces $220K seed round led by InSynchrony

FORT COLLINS -- Cetya Therapeutics, Inc . announced the closing of a $220,000 seed round financing funded by private investors -- including company insiders -- and InSynchrony Ventures Inc., a... Read More

Tuesday May 9, 2017 0 comments Tags: Fort Collins, Ceyta Therapeutics, InSynchrony, Rudi Erlemann, Cliff Hendrick, HDACs, Dean Wenham

Ampio initiates pivotal Ampion osteoarthritis trial

Ampio initiates pivotal Ampion osteoarthritis trial

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) announced it has begun a single injection study to meet the unmet medical need of treating the severe pain and loss of function... Read More

Monday May 1, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Dr. David Bar-Or, Chris Ehrlich, Michael Macaluso

i2 Pharmaceuticals appoints Mark Kubik CBO

i2 Pharmaceuticals appoints Mark Kubik CBO

BOULDER -- i2 Pharmaceuticals, Inc. , a biopharmaceutical company focused on next generation discovery and development of therapeutics with a focus on personalized cancer treatment, announced ... Read More

Friday April 28, 2017 0 comments Tags: Boulder, i2 Pharmaceuticals, Mark Kubik, Bruce Eaton